416 related articles for article (PubMed ID: 27681114)
1. Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin.
Hirai K; Ishii H; Shimoshikiryo T; Shimomura T; Tsuji D; Inoue K; Kadoiri T; Itoh K
Ther Drug Monit; 2016 Dec; 38(6):706-710. PubMed ID: 27681114
[TBL] [Abstract][Full Text] [Related]
2. Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance.
Hirai K; Ihara S; Kinae A; Ikegaya K; Suzuki M; Hirano K; Itoh K
Ther Drug Monit; 2016 Jun; 38(3):393-7. PubMed ID: 27172381
[TBL] [Abstract][Full Text] [Related]
3. Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function.
Ishii H; Hirai K; Sugiyama K; Nakatani E; Kimura M; Itoh K
Ther Drug Monit; 2018 Dec; 40(6):693-698. PubMed ID: 30157096
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
[TBL] [Abstract][Full Text] [Related]
5. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
[TBL] [Abstract][Full Text] [Related]
6. Augmented renal clearance--an evolving risk factor to consider during the treatment with vancomycin.
Minkutė R; Briedis V; Steponavičiūtė R; Vitkauskienė A; Mačiulaitis R
J Clin Pharm Ther; 2013 Dec; 38(6):462-7. PubMed ID: 23924288
[TBL] [Abstract][Full Text] [Related]
7. Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance.
Molina KC; Hall ST; Barletta JF; Mangram AJ; Dzandu JK; Huang V
Surg Infect (Larchmt); 2020 Feb; 21(1):43-47. PubMed ID: 31335259
[No Abstract] [Full Text] [Related]
8. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
Ishigo T; Ibe Y; Fujii S; Kazuma S; Aigami T; Kashiwagi Y; Takada R; Takahashi S; Fukudo M; Toda T
J Infect Chemother; 2023 Aug; 29(8):769-777. PubMed ID: 37150254
[TBL] [Abstract][Full Text] [Related]
9. Clinical applicability of urinary creatinine clearance for determining the initial dose of vancomycin in critically ill patients.
Mikami R; Imai S; Hayakawa M; Sugawara M; Takekuma Y
J Infect Chemother; 2022 Feb; 28(2):199-205. PubMed ID: 34686459
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
Belabbas T; Yamada T; Egashira N; Hirota T; Suetsugu K; Mori Y; Kato K; Akashi K; Ieiri I
J Infect Chemother; 2023 Apr; 29(4):391-400. PubMed ID: 36682608
[TBL] [Abstract][Full Text] [Related]
12. Influence of cerebral fluid drainage on the pharmacokinetics of vancomycin in neurosurgical patients.
Ichie T; Urano K; Suzuki D; Okada T; Kobayashi N; Hayashi H; Sugiura Y; Yamamura K; Sugiyama T
Pharmazie; 2015 Jun; 70(6):404-9. PubMed ID: 26189303
[TBL] [Abstract][Full Text] [Related]
13. Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Baptista JP; Sousa E; Martins PJ; Pimentel JM
Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742
[TBL] [Abstract][Full Text] [Related]
14. A Regression Model to Predict Augmented Renal Clearance in Critically Ill Obstetric Patients and Effects on Vancomycin Treatment.
Tang L; Ding XY; Duan LF; Li L; Lu HD; Zhou F; Shi L; Lu J; Shen Y; Zhuang ZW; Sun JT; Zhou Q; Zhu CQ; Li JJ; Yu YX
Front Pharmacol; 2021; 12():622948. PubMed ID: 34177564
[No Abstract] [Full Text] [Related]
15. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
Pea F; Porreca L; Baraldo M; Furlanut M
J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
[TBL] [Abstract][Full Text] [Related]
16. [Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment].
Campassi ML; Gonzalez MC; Masevicius FD; Vazquez AR; Moseinco M; Navarro NC; Previgliano L; Rubatto NP; Benites MH; Estenssoro E; Dubin A
Rev Bras Ter Intensiva; 2014; 26(1):13-20. PubMed ID: 24770684
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of predictability for vancomycin dosage regimens by the Bayesian method with Japanese population pharmacokinetic parameters.
Teramachi H; Hatakeyama H; Matsushita R; Imai Y; Miyamoto K; Tsuji A
Biol Pharm Bull; 2002 Oct; 25(10):1333-8. PubMed ID: 12392090
[TBL] [Abstract][Full Text] [Related]
18. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
[TBL] [Abstract][Full Text] [Related]
20. Bayesian estimation of pharmacokinetic parameters of vancomycin in patients with decreasing renal function.
Yamamoto T; Terakawa H; Hisaka A; Suzuki H
J Pharm Sci; 2012 Aug; 101(8):2968-75. PubMed ID: 22570265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
